Cannabis Sativa Inc
Change company Symbol lookup
Select an option...
CBDS Cannabis Sativa Inc
ERIC Telefonaktiebolaget LM Ericsson
EPD Enterprise Products Partners LP
AGL agilon health Inc
HBAN Huntington Bancshares Inc
MOGO Mogo Inc
VYGR Voyager Therapeutics Inc
PDAC^ Peridot Acquisition Corp
ABB Abb Ltd
TLT iShares 20+ Year Treasury Bond ETF

Health Care : Health Care Providers & Services | Small Cap Blend
Company profile

Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses. It holds the license for a medicinal cannabis strain called NZT, a cannabis lozenge delivery methodology, and a cannabis trauma cream formula. The Company is also developing a third strain of cannabis plant named CT22. The Company also conducts its operations through its subsidiary, Wild Earth Naturals, Inc. (Wild Earth). Wild Earth is an herbal skin care products formulation and marketing company that plans to target the natural healthcare products market in the United States and abroad. It offers Go Deep, Go Deep EXTRA (GDX), Face Garden, Body Garden and Lip Garden.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:



6 providers
June 10, 2021
The Global Legal Marijuana Market Size & Sales Will Reach USD 97 Billion by 2026: Research Report by Facts & Factors

Facts and Factors have published a new research report titled "Legal Marijuana Market by Product Type (Buds/marijuana Flower, Cannabis Extracts, Oil, Tinctures) & Others, Species (Cannabis Indica, Cannabis Sativa, Cannabis Hybrid)...(Globe Newswire)

May 18, 2021
Cannabis Sativa Announces Q1 2021 Revenues

MESQUITE, NV / ACCESSWIRE / May 18, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces Q1 2021 revenues of $557,323. PrestoDoctor subsidiary operations contributed $482,350 in gross revenue, with margins of 62% of revenue. Revenues grew 13% in the...(Accesswire)

May 04, 2021
THC Farmaceuticals, Inc. Acquires Controlling Interest in G.K. Manufacturing from Cannabis Sativa, Inc.

CBDual Biotechnology Corp's parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer of a unique line of premium CBD based oral health products as well as Dr. Rubin's Dental Anxiety Pills, today announced that it had reached a binding...(Globe Newswire)

April 20, 2021
Cannabis Sativa Reports Revenue Increase of 75% in 2020

MESQUITE, NV / ACCESSWIRE / April 20, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to report Revenue for the fiscal year ended December 31, 2020 of $2,035,383, up by 75% from 2019 revenues of $1,159,737. Cost of revenues for the fiscal years...(Accesswire)

April 15, 2021
PrestoDoctor to Offer On-site Evaluations at Pennsylvania Cannabis Festival April 17-18

MESQUITE, NV / ACCESSWIRE / April 15, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor will offer on-site evaluations at the Pennsylvania Cannabis Festival "Freedom Through Growth" live event on April 17 & 18 at...(Accesswire)

April 13, 2021
Global Medical Marijuana Market (2021 to 2025) - Featuring Aurora Cannabis, Cannabis Sativa & Canopy Growth Among Others

The "Global Medical Marijuana Market 2021-2025" report has been added to's offering. The publisher has been monitoring the medical marijuana market and it is poised to grow by $27.72 billion during 2021-2025, progressing at a...(Globe Newswire)

April 06, 2021
Global Hemp Fiber Market Size & Analysis - Forecast to 2026

According to a new market research report published by Global Market Estimates, the Hemp Fiber Market will grow with a high CAGR value over the forecast period [2021 to 2026]. Hemp Fiber (Cannabis Sativa) is noted to be the most versatile natural...(Globe Newswire)

March 17, 2021
Tauriga Sciences Inc. Commences Development of Delta-8-THC Infused Version of Tauri-Gum

via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.